542 related articles for article (PubMed ID: 37051026)
1. Pathophysiology and new advances in pulmonary hypertension.
Bousseau S; Sobrano Fais R; Gu S; Frump A; Lahm T
BMJ Med; 2023; 2(1):e000137. PubMed ID: 37051026
[TBL] [Abstract][Full Text] [Related]
2.
Cuthbertson I; Morrell NW; Caruso P
Circ Res; 2023 Jan; 132(1):109-126. PubMed ID: 36603064
[TBL] [Abstract][Full Text] [Related]
3. The Role of Sex in the Pathophysiology of Pulmonary Hypertension.
Docherty CK; Harvey KY; Mair KM; Griffin S; Denver N; MacLean MR
Adv Exp Med Biol; 2018; 1065():511-528. PubMed ID: 30051404
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-424(322) as a new marker of disease progression in pulmonary arterial hypertension and its role in right ventricular hypertrophy by targeting SMURF1.
Baptista R; Marques C; Catarino S; Enguita FJ; Costa MC; Matafome P; Zuzarte M; Castro G; Reis A; Monteiro P; Pêgo M; Pereira P; Girão H
Cardiovasc Res; 2018 Jan; 114(1):53-64. PubMed ID: 29016730
[TBL] [Abstract][Full Text] [Related]
5. Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension.
Antigny F; Mercier O; Humbert M; Sabourin J
Arch Cardiovasc Dis; 2020 Jan; 113(1):70-84. PubMed ID: 31924541
[TBL] [Abstract][Full Text] [Related]
6. [Female gender and pulmonary arterial hypertension: a complex relationship].
Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
[TBL] [Abstract][Full Text] [Related]
7. Cardiac remodelling in a swine model of chronic thromboembolic pulmonary hypertension: comparison of right vs. left ventricle.
Stam K; Cai Z; van der Velde N; van Duin R; Lam E; van der Velden J; Hirsch A; Duncker DJ; Merkus D
J Physiol; 2019 Sep; 597(17):4465-4480. PubMed ID: 31194256
[TBL] [Abstract][Full Text] [Related]
8. Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
Vizza CD; Lang IM; Badagliacca R; Benza RL; Rosenkranz S; White RJ; Adir Y; Andreassen AK; Balasubramanian V; Bartolome S; Blanco I; Bourge RC; Carlsen J; Camacho REC; D'Alto M; Farber HW; Frantz RP; Ford HJ; Ghio S; Gomberg-Maitland M; Humbert M; Naeije R; Orfanos SE; Oudiz RJ; Perrone SV; Shlobin OA; Simon MA; Sitbon O; Torres F; Luc Vachiery J; Wang KY; Yacoub MH; Liu Y; Golden G; Matsubara H
Am J Respir Crit Care Med; 2022 Apr; 205(7):751-760. PubMed ID: 34905704
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension: the science behind the disease spectrum.
Wilkins MR
Eur Respir Rev; 2012 Mar; 21(123):19-26. PubMed ID: 22379170
[TBL] [Abstract][Full Text] [Related]
10. Targeting epigenetic mechanisms as an emerging therapeutic strategy in pulmonary hypertension disease.
Bisserier M; Janostiak R; Lezoualc'h F; Hadri L
Vasc Biol; 2020 Jan; 2(1):R17-R34. PubMed ID: 32161845
[TBL] [Abstract][Full Text] [Related]
11. [New insights in the pathogenesis of pulmonary arterial hypertension].
Bordenave J; Tu L; Savale L; Huertas A; Humbert M; Guignabert C
Rev Mal Respir; 2019 Apr; 36(4):433-437. PubMed ID: 31010759
[TBL] [Abstract][Full Text] [Related]
12. Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Benza RL; Langleben D; Hemnes AR; Vonk Noordegraaf A; Rosenkranz S; Thenappan T; Hassoun PM; Preston IR; Ghio S; Badagliacca R; Vizza CD; Lang IM; Meier C; Grünig E
Eur Respir Rev; 2022 Dec; 31(166):. PubMed ID: 36198418
[TBL] [Abstract][Full Text] [Related]
13. Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension.
Perros F; Humbert M; Dorfmüller P
Eur Respir Rev; 2021 Dec; 30(162):. PubMed ID: 34937704
[TBL] [Abstract][Full Text] [Related]
14. The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.
Ryan JJ; Archer SL
Circ Res; 2014 Jun; 115(1):176-88. PubMed ID: 24951766
[TBL] [Abstract][Full Text] [Related]
15. Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failure.
Suen CM; Chaudhary KR; Deng Y; Jiang B; Stewart DJ
Cardiovasc Res; 2019 Mar; 115(4):788-799. PubMed ID: 30357319
[TBL] [Abstract][Full Text] [Related]
16. Vascular remodeling in pulmonary hypertension.
Shimoda LA; Laurie SS
J Mol Med (Berl); 2013 Mar; 91(3):297-309. PubMed ID: 23334338
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of right ventricular dysfunction in pulmonary arterial hypertension: focus on the coronary vasculature, sex hormones, and glucose/lipid metabolism.
Agrawal V; Lahm T; Hansmann G; Hemnes AR
Cardiovasc Diagn Ther; 2020 Oct; 10(5):1522-1540. PubMed ID: 33224772
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary arterial hypertension - progress in understanding the disease and prioritizing strategies for drug development.
Ghataorhe P; Rhodes CJ; Harbaum L; Attard M; Wharton J; Wilkins MR
J Intern Med; 2017 Aug; 282(2):129-141. PubMed ID: 28524624
[TBL] [Abstract][Full Text] [Related]
19. Molecular Pathways in Pulmonary Arterial Hypertension.
Shah AJ; Vorla M; Kalra DK
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077398
[TBL] [Abstract][Full Text] [Related]
20. Sex Dimorphism in Pulmonary Hypertension: The Role of the Sex Chromosomes.
Kostyunina DS; McLoughlin P
Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34068984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
